Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000294363 is annotated as a novel long non-coding RNA (lncRNA) transcript, transcribed in the antisense orientation to the BST1 gene[1][3][5]. lncRNAs typically do not encode proteins and may function in gene expression regulation, though the biological roles of many lncRNAs remain unclear. For this specific transcript, there is no evidence of protein-coding capability, therapeutic target relevance, or well-defined biological/disease roles in major gene, protein, or therapeutic target databases. It is not regarded as a conventional "target molecule" (e.g., receptor, enzyme, transporter)[3][5]. This entry is not a well-defined molecular target. It is not a receptor, enzyme, transporter, or a protein-coding gene. There is insufficient information to classify it as a druggable, disease-relevant, or mechanistically significant target; its physiological and pathological relevance is unknown. If you are seeking information about BST1 (bone marrow stromal antigen 1), that is a distinct protein-coding gene and a recognized target in immune and neurological research[9]. This "novel transcript, antisense to BST1" is simply an uncharacterized non-coding RNA overlapping the BST1 locus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to BST1 (ENSG00000294363).